Psychiatry Research
Volume 179, Issue 2 , Pages 126-129 , 30 September 2010

Testing the antagonistic pleiotropy model of schizophrenia susceptibility by analysis of DAOA, PPP1R1B, and APOL1 genes

  • Noa Carrera

      Affiliations

    • Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain
    • ,
  • Manuel Arrojo

      Affiliations

    • Servicio de Psiquiatría, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
    • ,
  • Eduardo Paz

      Affiliations

    • Servicio de Psiquiatría, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
    • ,
  • Ramón Ramos-Ríos

      Affiliations

    • Servicio de Psiquiatría, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
    • ,
  • Santiago Agra

      Affiliations

    • Servicio de Psiquiatría, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
    • ,
  • Mario Páramo

      Affiliations

    • Servicio de Psiquiatría, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
    • ,
  • Julio Brenlla

      Affiliations

    • Servicio de Psiquiatría, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
    • ,
  • Javier Costas

      Affiliations

    • Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain
    • Corresponding Author InformationCorresponding author. Fundación Pública Galega de Medicina Xenómica-SERGAS, Hospital Clínico Universitario de Santiago, Edif. Consultas Planta -2, E-15706 Santiago de Compostela, Spain. Tel.: +34 981951490; fax: +34 981951473.

Received 25 November 2008 ,Revised 16 April 2009 ,Accepted 26 May 2009.

References 

  1. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265
  2. Blekhman R, Man O, Herrmann L, Boyko AR, Indap A, Kosiol C, et al. Natural selection on genes that underlie human disease susceptibility. Current Biology. 2008;18:883–889
  3. Carrera N, Sanjuán J, Moltó MD, Carracedo A, Costas J. Recent adaptive selection at MAOB and ancestral susceptibility to schizophrenia. American Journal of Medical Genetics series B Neuropsychiatric Genetics. 2009;150B:369–374
  4. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:13675–13680
  5. Costas J, Salas A, Phillips C, Carracedo A. Human genome-wide screen of haplotype-like blocks of reduced diversity. Gene. 2005;349:219–225
  6. Crespi B, Summers K, Dorus S. Adaptive evolution of genes underlying schizophrenia. In: Proceedings. Biological Sciences. The Royal Society. vol. 274:2007;p. 2801–2810
  7. Di Rienzo A, Hudson RR. An evolutionary framework for common diseases: the ancestral-susceptibility model. Trends in Genetics. 2005;21:596–601
  8. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Human Heredity. 2008;66:87–98
  9. Hansen C, Greengard P, Nairn AC, Andersson T, Vogel WF. Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1. Experimental Cell Research. 2006;312:4011–4018
  10. Haukka J, Suvisaari J, Lonnqvist J. Fertility of patients with schizophrenia, their siblings, and the general population: a cohort study from 1950 to 1959 in Finland. American Journal of Psychiatry. 2003;160:460–463
  11. Huxley J, Mayr E, Osmond H, Hoffer A. Schizophrenia as a genetic morphism. Nature. 1964;204:220–221
  12. International Schizophrenia Consortium . Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature. 2008;455:237–241
  13. Keller MC, Miller G. Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best?. The Behavioral and Brain Sciences. 2006;29:385–404discussion 405–452
  14. Kelley JL, Madeoy J, Calhoun JC, Swanson W, Akey JM. Genomic signatures of positive selection in humans and the limits of outlier approaches. Genome Research. 2006;16:980–989
  15. Kryukov GV, Pennacchio LA, Sunyaev SR. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. American Journal of Human Genetics. 2007;80:727–739
  16. McGhee KA, Morris DW, Schwaiger S, Nangle JM, Donohoe G, Clarke S, et al. Investigation of the apolipoprotein-L (APOL) gene family and schizophrenia using a novel DNA pooling strategy for public database SNPs. Schizophrenia Research. 2005;76:231–238
  17. Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, et al. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. Journal of Clinical Investigation. 2007;117:672–682
  18. Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RL, et al. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:4680–4685
  19. Opgen-Rhein C, Lencz T, Burdick KE, Neuhaus AH, DeRosse P, Goldberg TE, et al. Genetic variation in the DAOA gene complex: impact on susceptibility for schizophrenia and on cognitive performance. Schizophrenia Research. 2008;103:169–177
  20. Pearlson GD, Folley BS. Schizophrenia, psychiatric genetics, and Darwinian psychiatry: an evolutionary framework. Schizophrenia Bulletin. 2008;34:722–733
  21. Roig B, Virgos C, Franco N, Martorell L, Valero J, Costas J, et al. The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia. Molecular Psychiatry. 2007;12:833–841
  22. Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, Schaffner SF, et al. Detecting recent positive selection in the human genome from haplotype structure. Nature. 2002;419:832–837
  23. Sabeti PC, Schaffner SF, Fry B, Lohmueller J, Varilly P, Shamovsky O, et al. Positive natural selection in the human lineage. Science. 2006;312:1614–1620
  24. Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, Steinberg S, et al. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455:232–236
  25. Takahashi S, Cui YH, Han YH, Fagerness JA, Galloway B, Shen YC, et al. Association of SNPs and haplotypes in APOL1 2 and 4 with schizophrenia. Schizophrenia Research. 2008;104:153–164
  26. The International HapMap Consortium . A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449:851–861
  27. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, Van Den Abbeele J, et al. Apolipoprotein L-1 is the trypanosome lytic factor of human serum. Nature. 2003;422:83–87
  28. Voight BF, Kudaravalli S, Wen X, Pritchard JK. A map of recent positive selection in the human genome. PLoS Biology. 2006;4(3):e72.1
  29. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320:539–543

PII: S0165-1781(09)00197-8

doi: 10.1016/j.psychres.2009.05.014

Psychiatry Research
Volume 179, Issue 2 , Pages 126-129 , 30 September 2010

Article Tools

* Image Usage & Resolution